Education
About Us
Working with TipRanks
Follow Us
Can-Fite BioPharma (CANF)
:CANF
Piclidenoson
Plaque Psoriasis
Phase III
Not Yet Recruiting
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Oct 09, 2024
―
Namodenoson 25Mg
Pancreatic Cancer, Pancreatic Adenocarcinoma
Phase II
Recruiting
Namodenoson Treatment of Advanced Pancreatic Cancer
Apr 15, 2024
―
Namodenoson
Hepatocellular Carcinoma, Cirrhosis
Phase III
Recruiting
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Dec 21, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Can-Fite BioPharma (CANF) have in its pipeline
CANF is currently developing the following drugs: Piclidenoson, Namodenoson 25Mg, Namodenoson. These drug candidates are in various stages of clinical development as the company works toward FDA approval.